A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacodynamics of SYNB8802 in Healthy Volunteers and in Patients with Enteric Hyperoxaluria07/13/2021 - 07/13/2024 (PI)
Synlogic Operating Company. Inc
ETHICON Endo-Surgery Fellowship07/01/2010 - 06/30/2011 (PI)
ETHICON Endo-Surgery, Inc